Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial - Armstrong, A J; Halabi, S; Eisen, T (Lancet Oncol, 2016)
epub ahead of print